|
|
Notice to extraordinary general meeting in Scibase Holding AB (publ) |
|
|
SciBase announces collaboration for prediction of atopic dermatitis in infants |
|
|
Interim report January 1 - September 30, 2024 |
|
|
SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million |
|
|
SciBase initiates sales collaboration in Italy |
|
|
SciBase continues US expansion and will attend Fall Clinical conference |
|
|
Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2025 |
|
|
SciBase announces sale of Nevisense to NIH (US) |
|
|
SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice |
|
|
New US Consensus Report supports Nevisense |
